An additional special guest to the M&A Panel: Andrew Liu, VP Global Corporate Development at Chengdu Kanghong Pharmaceutical Group will be joining us.
Chengdu Kanghong Pharmaceutical is a public multi-billion dollar Chinese firm which recently invested in the Israeli company IOPtima.
.png?cache=1525272070978)